Nutrition & Lifestyle

Retatrutide

Retatrutide Protein Intake

Updated August 8, 2026

Retatrutide is an investigational medication in clinical trials. It is not FDA-approved, is not legally compoundable, and is not available through Trimi. Trimi does not offer it and has no plans to. This article is editorial safety coverage for people researching the drug-development pipeline.

This article is general information, not medical or nutritional advice. Protein needs vary with kidney function and other conditions. Consult a licensed clinician or registered dietitian before making significant dietary changes.

Sources & References

Jastreboff AM et al. Triple-Hormone-Receptor Agonist Retatrutide for Obesity: A Phase 2 Trial. NEJM 2023. pubmed.ncbi.nlm.nih.gov/37366315
Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). NEJM 2021. pubmed.ncbi.nlm.nih.gov/33567185
Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). NEJM 2022. pubmed.ncbi.nlm.nih.gov/35658024
U.S. Food and Drug Administration. Human Drug Compounding. fda.gov/drugs/human-drug-compounding
ClinicalTrials.gov, U.S. National Library of Medicine. clinicaltrials.gov

What should patients know about preserving lean muscle mass during weight loss?

Peer-reviewed / regulatory evidence: Published meta-analyses of caloric-restriction interventions estimate that, without resistance training, approximately 20-30% of total weight loss is lean (fat-free) mass. Adequate dietary protein intake (~1.2-1.6 g/kg body weight) combined with resistance training significantly reduces this loss. (Source: Sardeli et al., Nutrients 2018). Trimi's clinical review, provided through Arora Health's 50-state provider network (whose providers include Dr. Sean Arora, MD, the network's founder), addresses preserving lean muscle mass during weight loss as part of the individualized patient-care plan. Compounded medications are dispensed by a 503A community sterile compounding pharmacy (BelieveRx). This is general information based on the cited sources, not medical advice.

Published meta-analyses of caloric-restriction interventions estimate that, without resistance training, approximately 20-30% of total weight loss is lean (fat-free) mass. Adequate dietary protein intake (~1.2-1.6 g/kg body weight) combined with resistance training significantly reduces this loss., Sardeli et al., Nutrients 2018

Key Takeaways

Published meta-analyses of caloric-restriction interventions estimate that, without resistance training, approximately 20-30% of total weight loss is lean (fat-free) mass. Adequate dietary protein intake (~1.2-1.6 g/kg body weight) combined with resistance training significantly reduces this loss. (Source: Sardeli et al., Nutrients 2018)
Adequate dietary protein intake (approximately 1.2-1.6 g/kg body weight) combined with resistance training significantly reduces lean-mass loss during rapid weight loss. Discuss specific intake targets and exercise programming with your prescribing clinician.
GLP-1 receptor agonists require a prescription. Eligibility is determined by a licensed clinician based on BMI, weight-related comorbidities, and screening for contraindications (medullary thyroid carcinoma history, MEN 2, pancreatitis history, severe GI / renal disease, pregnancy, breastfeeding).
This is general information based on the cited sources, not medical advice. Treatment decisions require evaluation by a licensed clinician.

Medically Reviewed

TMRT

Trimi Medical Review Team

Clinical review workflow for GLP-1 safety, dosing, and access content

Team-based medical review process documented in Trimi's Medical Review Policy

Last reviewed: August 8, 2026

TCCT

Written by Trimi Clinical Content Team

Medical Writers & Healthcare Professionals

Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

Medically reviewed by Trimi Medical Review Team, Clinical review workflow for GLP-1 safety, dosing, and access content

What real Trimi patients say

Verbatim quotes from Trimi's Facebook and Reddit community reviews. First name and last initial preserved per editorial policy.

Arrived within 24 hours. Easy to use. Comes with everything. The year is so worth it.

- Veronica L.Facebook

It's only been 2 weeks since I've been taking the VialsRx meds from Trimi. The medication showed up pretty quickly (about 4 days after getting approval from Trimi prescriber) and I received 3 vials for my first 3 months on the subscription. For the price and convenience my take is that Trimi and VialsRx is good.

- u/CSWB101Reddit (r/TirzepatideRX)

See all community reviews →

Editorial Standards

Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

Scientific References

Heymsfield SB, Coleman LA, Miller R, et al. (2021). Effect of Bimagrumab vs Placebo on Body Fat Mass Among Adults With Type 2 Diabetes and Obesity: A Phase 2 Randomized Clinical Trial. JAMA Network Open.Read StudyDOI: 10.1001/jamanetworkopen.2020.33457
Sardeli AV, Komatsu TR, Mori MA, et al. (2018). Resistance Training Prevents Muscle Loss Induced by Caloric Restriction in Obese Elderly Individuals: A Systematic Review and Meta-Analysis. Nutrients.Read StudyDOI: 10.3390/nu10040423
Phillips SM, Chevalier S, Leidy HJ (2016). Protein 'requirements' beyond the RDA: implications for optimizing health. Applied Physiology, Nutrition, and Metabolism.Read StudyDOI: 10.1139/apnm-2015-0550

Was this article helpful?

Keep Reading